Opening doors to the US healthcare market with Health3-2-1!

The week is off to a great start at AdvaMed’s The MedTech Conference, where 14 Nordic-Baltic medtech companies from our Interreg Health3-2-1 project are exploring opportunities in the US healthcare market.

From understanding FDA regulations and reimbursement pathways to learning how to navigate market access, the programme is packed with valuable insights and opportunities to connect with industry experts and potential partners.

For life science companies it’s about understanding a new healthcare system, building the right relationships and finding a path to bring innovation to the people who need it.

That’s where cross-border collaboration makes a difference. By bringing together expertise and companies from Sweden, Finland and Estonia, Health3-2-1 helps turn knowledge into opportunities and supports Nordic-Baltic innovation on its journey towards international markets.

Great to see our participating companies making the most of this opportunity. Looking forward to more conversations, connections and new possibilities!